The prognostic value of HER-2/neu oncogene in cervical cancer

Annals of Clinical and Laboratory Science

Volumn 27, Issue 6, 1997, Pages 396-401

  Ndubisi, Boniface ^a   Sanz, Sara ^a   Lu, Leo ^a   Podczaski, Edward ^b   Benrubi, Guy ^a   Masood, Shahla ^a  

^a UNIVERSITY OF FLORIDA HEALTH SCIENCE CENTER   (United States)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE COURSE; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; ONCOGENE NEU; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA;

FEMALE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM STAGING; ONCOGENES; PROGNOSIS; RECEPTOR, ERBB-2; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; UTERINE CERVICAL NEOPLASMS;

EID: 0031436441     PISSN: 00917370     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Slamon DJ, Clark GM, Wong SG, et al. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 1987; 235:177.
2. Slamon DJ, Godolphin W, Jones LA, et al. Studies of HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 1989;244:707.
3. Berchuck A, Kamel A, Whitaker R, et al. Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer. Cancer Res 1990; 50:4087.
4. Berchuck A, Rodriguez G, Kinney RB, et al. Overexpression of HER-2/neu in endometrial cancer is associated with advanced stage disease. Am J Obstet Gynecol 1991;164:15.
5. Beahrs OH, Henson DE, Hutter RVP, Myers MH, et al. Manual for Staging of Cancer, 3rd ed. Philadelphia: JB Lippincott, 1988:151-3.
6. Scully RE, Bonfiglio T, Kurman JR, et al. World Health Organization International Histological Classification of Tumors, Histological Typing of Female Genital Tract Tumors, 2nd ed. Berlin: Springer-Verlag, 1994.
7. Berchuck A, Rodriguez G, Kamel A, et al. Expression of epidermal growth factor receptor and HER-2/neu in normal and neoplastic cervix, vulva, and vagina. Obstet Gynecol 1990;76:381.
8. Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958;53: 457-81.
9. Benedetti J, Yuen K, Young L. In: Dixon WI, Brown MB, Engelman L, Jennrich RI, editors. Life tables and survivor functions in BMDP statistical software manual, vol. 2. Berkeley: University of California Press, 1990:739-68.
10. Hopkins A. In: Dixon WI, Brown MB, Engelman L, Jennrich RI, editors. Survival analysis with covariates in BMDP statistical software manual, vol 2. Berkeley: University of California Press, 1990:769-806.